Skip to main content

Table 2 Outcomes of interest at the end of follow-up (December 31th, 2010) in 1,678 opiate users admitted to a methadone treatment program between 1992-2010

From: Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study

  Men Women p value
  n = 1,390 n = 298  
Total follow-up length (p-y) 12,356 2,768  
Median follow-up (IQR), years 9.1 (3.8-12.8) 9.6 (4.9-13.8) 0.097
Deaths, n (%) 371 (26.7) 70 (24.3) 0.403
Mortality Rate, per 100 p-y (95% CI) 3.0 (2.7-3.3) 2.5 (2.0-3.2) 0.187
Causes of death (n = 425)    0.022
HIV/AIDS 134 (37.3) 35 (53.0)  
Non-natural 104 (29.0) 8 (12.1)  
Liver 38 (10.6) 8 (12.1)  
Other 83 (23.1) 15 (22.7)